Recruiting
Trisomy 21
RecruitingInvestigational
Study of AEF0217 compared to placebo for improving behavior and thinking skills in adults and older adolescents with Down syndrome
Investigational
- Disease:Trisomy 21
- Substances:1-((3S,8S,9S,10R,13S,14S,17S)3-BENZYLOXY-10,13,17-TRIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1HCYCLOPENTA[A]PHENANTHRENE-17-YL)ETHAN-1-ONE
Countries:
France
France- Participants:0–17 years · 18–64 years
- Substances:1-((3S,8S,9S,10R,13S,14S,17S)3-BENZYLOXY-10,13,17-TRIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1HCYCLOPENTA[A]PHENANTHRENE-17-YL)ETHAN-1-ONE










